685 US HIGHWAY ONE, NORTH BRUNSWICK, NJ
Pelthos Therapeutics Dismisses CBIZ as Independent Auditor
Announces First Quarter 2026 Financial Results
Reg. FD
Announces CFO Transition
Investor Presentation
Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Definitive Merger Information Statement